Agenda
Paper No:
MEETING:
PUBLIC BOARD MEETING
DATE:
Wednesday 15 February 2012
9
CM/01/12/08
TITLE OF PAPER: CQC Business Planning and budget 2012-13
SUMMARY:
To ask the Board to agree the final draft 2012-13 Business plan and budget, prior to formal
submission the Department of Health.
RECOMMENDED ACTION:
The Board is invited to COMMENT on the draft business plan.
Executive Decision/
Board for
information
Executive and Board
decision
Executive and Board
shared decision
Executive and Board
discussion/Board
decision
* Check box as required
LEAD DIRECTOR:
John Lappin, Director of Finance and Corporate Services
AUTHOR:
Robin Wilson, Corporate Planning Manager
DIRECTORATE
Finance and Corporate Services
DATE:
February 2012
SUPPORTING PAPERS: Annex A - Business plan
Annex B – Our regulatory model explained
Page 1 of 4
Agenda
Paper No:
GOVERNANCE
AUDIT TRAIL:
9
CM/01/12/08
The Board was consulted on the draft plan in January.
This paper has been agreed by the Executive Team.
LINK TO STRATEGIC
OBJECTIVES AND
BUSINESS PLAN
FINANCIAL IMPACT:
The Business Plan includes the new priority relating to
reviewing and refining our Strategy.
RISK IMPACT:
Risk issues will be addressed as part of both strategic
and directorate level business planning.
REPUTATION IMPACT:
A robust business planning exercise and performance
measures are necessary to ensure DH agreement to our
business plan and public credibility.
HEALTHWATCH IMPACT:
HealthWatch England budgetary requirements are part of
financial planning for 2012-13.
EQUALITY IMPACT
ASSESSMENT:
An EIA has been completed as part of the corporate
business plan, and is included as an Annex to it.
Budget is addressed in the business plan.
Page 2 of 4
Agenda
Paper No:
1.
9
CM/01/12/08
Background
1.1 The attached draft 2012-13 business plan, including budget, is submitted to the
Board for final approval.
2.
Executive Summary
2.1 The Board commented on the draft business plan at their January meeting, and
subsequently we received more detailed comments from a number of Board
members. These comments have informed further work on the current version of the
plan presented here. In addition, we met a number of DH officials on 19 January and
received extremely positive feedback on the draft business plan. The DH commented
that it was ‘Very reassuring to see the focus on inspections and taking on board all
the comments from the PAC, NAO, etc.’ That it ‘is a public facing document’ and that
they ‘appreciated the forward-thinking contained in the document particularly with
HealthWatch England’.
2.2 The purpose of bringing the plan to the Board now is to request formal sign-off. We
will then submit the amended plan to DH for their approval, which will include
approval of our budget. We are informed this approval is expected by the end of
February.
2.3 Key changes to the business plan since the Board last saw it are:








Further emphasis on our partnership working with other regulators and parts of
the system
Reference to involvement activity in Mental Health Act work
Re-ordering the Priorities – 1. Deliver our Regulatory and other functions; 2.
Review and Refine our strategy; 3. Manage our people and resources
To amend the wording of Priority 2 to allow for further iteration to finalise the
elements of this work following further discussion with the Board at the February
Strategy session.
Add further content on the extensive stakeholder work we have planned
Make clear the elements that are subject to successful passage of the Health and
Social Care Bill
To add the Equality and Human Rights Impact Assessment we have carried out
on the business plan
The inclusion of an accompanying document ‘Our regulatory model explained’ –
giving further context and detail about the regulatory model.
2.4 We have also been working to transfer the success measures in the business plan
into the reportable KPIs that will form our scorecard, through which we will report on
our performance to the Board on a quarterly basis. The scorecard will continue to
form the key document for the DH to discuss performance in our regular
accountability meetings. Mental Health Act activity measures are being reviewed –
and the current draft of these measures have been included in the business plan in
section 2.5. The Board is invited to comment on these, and whether they wish to
receive performance reports against all the measures, or some.
2.5 We have begun a process of more detailed Directorate level business planning,
which will see Directorate plans drawn up that closely align to the priorities in our
corporate business plan; and assign appropriate ownership for the actions and
Page 3 of 4
Agenda
Paper No:
9
CM/01/12/08
performance measures in the business plan. The Directorate plans will together
comprise CQC’s operating-level plan
2.6 The revenue and capital budgets are shown on pages 26/27 of the plan. As reported
in January there remain a number of demands on the capital budget and we continue
to work through the details of each area of demand, and whilst the position is still
‘tight’ our confidence on affordability remains reasonably high.
3.
Conclusion
3.1 The Board is invited to agree the business plan and budget.
4.
Next Steps
4.
Subject to the Board’s agreement we will submit the business plan to the DH shortly
after the meeting. Following approval we will publish the plan and the accompanying
document on our website.
Name: John Lappin,
Title: Director of Finance and Corporate Services
Date: 15 February 2012
Page 4 of 4